Trends in Illicit Cannabis Potency based on the Analysis of Law Enforcement Seizures in the Southern Area of Rome
Abstract
:1. Introduction
New Changes in Cannabis Potency
2. Materials and Methods
2.1. Standard Solutions and Reagents
2.2. Sample Description, Preparation and Analysis
3. Data Elaboration and Results
Epidemiologic Trends in Cannabis Resin-Related Arrests
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hao, D.C.; Gu, X.J.; Xiao, P.G. Phytochemical and biological research of Cannabis pharmaceutical resources. Med. Plants 2015, 431–464. [Google Scholar] [CrossRef]
- Bidwell, L.C.; Ellingson, J.M.; Karoly, H.C.; YorkWilliams, S.L.; Hitchcock, L.N.; Tracy, B.L.; Klawitter, J.; Sempio, C.; Bryan, A.D.; Hutchison, K.E. Association of Naturalistic Administration of Cannabis Flower and Concentrates with Intoxication and Impairment. JAMA Psychiatry 2020, 77, 787. [Google Scholar] [CrossRef] [PubMed]
- Crocq, M.A. History of cannabis and the endocannabinoid system. Dialogues Clin. Neurosci. 2020, 22, 223–228. [Google Scholar] [CrossRef]
- Radwan, M.M.; Chandra, S.; Gul, S.; ElSohly, M.A. Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules 2021, 26, 2774. [Google Scholar] [CrossRef]
- Sgrò, S.; Lavezzi, B.; Caprari, C.; Polito, M.; D’Elia, M.; Lago, G.; Furlan, G.; Girotti, S.; Ferri, E.N. Delta9-THC determination by the EU official method: Evaluation of measurement uncertainty and compliance assessment of hemp samples. Anal. Bioanal. Chem. 2021, 413, 3399–3410. [Google Scholar] [CrossRef]
- Gaoni, Y.; Mechoulam, R. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. J. Am. Chem. Soc. 1964, 86, 1646–1647. [Google Scholar] [CrossRef]
- Tanney, C.A.S.; Backer, R.; Geitmann, A.; Smith, D.L. Cannabis Glandular Trichomes: A Cellular Metabolite Factory. Front. Plant Sci. 2021, 12, 721986. [Google Scholar] [CrossRef] [PubMed]
- Stefkov, G.; Cvetkovikj Karanfilova, I.; Stoilkovska Gjorgievska, V.; Trajkovska, A.; Geskovski, N.; Karapandzova, M.; Kulevanova, S. Analytical Techniques for Phytocannabinoid Profiling of Cannabis and Cannabis-Based Products—A Comprehensive Review. Molecules 2022, 27, 975. [Google Scholar] [CrossRef] [PubMed]
- Borille, B.T.; González, M.; Steffens, L.; Ortiz, R.S.; Limberger, R.P. Cannabis sativa: A systematic review of plant analysis. Drug Anal. Res. 2017, 1, 1–23. [Google Scholar] [CrossRef]
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Cannabis Production and Markets in Europe; EMCDDA: Lisbon, Portugal, 2012. [CrossRef]
- Agarwal, C.; Máthé, K.; Hofmann, T.; Csóka, L. Ultrasound-Assisted Extraction of Cannabinoids from Cannabis sativa L. Optimized by Response Surface Methodology. J. Food Sci. 2018, 83, 700–710. [Google Scholar] [CrossRef]
- Grotenhermen, F. Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin. Pharmacokinet. 2003, 42, 327–360. [Google Scholar] [CrossRef]
- Hall, W.; Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374, 1383–1391. [Google Scholar] [CrossRef]
- Mullins, M.F. Cannabis dabbing. Nursing 2021, 51, 46–50. [Google Scholar] [CrossRef]
- Pertwee, R.G. The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008, 153, 199–215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lucas, C.J.; Galettis, P.; Schneider, J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018, 84, 2477–2482. [Google Scholar] [CrossRef] [Green Version]
- Le Boisselier, R.; Alexandre, J.; Lelong-Boulouard, V.; Debruyne, D. Focus on cannabinoids and synthetic cannabinoids. Clin. Pharmacol. Ther. 2017, 101, 220–229. [Google Scholar] [CrossRef]
- Hall, W.; Stjepanović, D.; Caulkins, J.; Lynskey, M.; Leung, J.; Campbell, G.; Degenhardt, L. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet 2019, 394, 1580–1590. [Google Scholar] [CrossRef] [PubMed]
- Rostam-Abadi, Y.; Gholami, J.; Amin-Esmaeili, M.; Baheshmat, S.; Hamzehzadeh, M.; Rafiemanesh, H.; Nasserbakht, M.; Ghalichi, L.; Safarcherati, A.; Taremian, F.; et al. Evidence for an increase in cannabis use in Iran—A systematic review and trend analysis. PLoS ONE 2021, 16, e0256563. [Google Scholar] [CrossRef] [PubMed]
- Degenhardt, L.; Hall, W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379, 55–70. [Google Scholar] [CrossRef] [PubMed]
- Jouanjus, E.; Lapeyre-Mestre, M.; Micallef, J. Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders. J. Am. Heart Assoc. 2014, 3, e000638. [Google Scholar] [CrossRef] [Green Version]
- Nourbakhsh, M.; Miller, A.; Gofton, J.; Jones, G.; Adeagbo, B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. J. Forensic Sci. 2019, 64, 270–274. [Google Scholar] [CrossRef] [Green Version]
- Drummer, O.H.; Gerostamoulos, D.; Woodford, N.W. Cannabis as a cause of death: A review. Forensic Sci. Int. 2019, 298, 298–306. [Google Scholar] [CrossRef]
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2022: Trends and Developments. 2022. Available online: https://www.emcdda.europa.eu/publications/edr/trends-developments/2022_en (accessed on 10 May 2023).
- United Nations Office on Drugs and Crimes (UNODC). World Drug Report 2022. Booklet 3. Drug Market Trends: Cannabis, Opioids. 2022. Available online: https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2022.html (accessed on 5 June 2023).
- Verri, P.; Rustichelli, C.; Ferrari, A.; Marchesi, F.; Baraldi, C.; Licata, M.; Vandelli, D.; Palazzoli, F.; Potì, F.; Silingardi, E. Seizures of illicit substances for personal use in two Italian provinces: Analysis of trends by type and purity from 2008 to 2017. Subst. Abus. Treat. Prev. Policy 2019, 14, 41. [Google Scholar] [CrossRef] [PubMed]
- United Nations Office on Drugs and Crimes (UNODC). World Drug Report 2021; United Nations Publication, Sales No. E.21.XI.8; United Nations: New York, NY, USA, 2021. [CrossRef]
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2023. 2023. Available online: https://www.emcdda.europa.eu/publications/european-drug-report/2023/cannabis_en#edr-2023-cannabis-source-data-table9 (accessed on 3 July 2023).
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2021: Trends and Developments. 2021. Available online: https://www.emcdda.europa.eu/publications/edr/trends-developments/2021_en (accessed on 15 June 2023).
- Schiavone, S. Il rilevamento delle droghe nei campioni da strada. Ann. Dell’istituto Super. Sanita 2004, 40, 441–446. [Google Scholar]
- United Nations Office on Drugs and Crime (UNODC). Guidelines on Representative Drug Samplig. 2011. Available online: https://www.unodc.org/unodc/en/scientists/guidelines-on-representative-drug-sampling_new.html (accessed on 6 July 2023).
- Dussy, F.E.; Hamberg, C.; Luginbühl, M.; Schwerzmann, T.; Briellmann, T.A. Isolation of Δ9-THCA-A from hemp and analytical aspects concerning the determination of Δ9-THC in cannabis products. Forensic Sci. Int. 2005, 149, 3–10. [Google Scholar] [CrossRef]
- Stanaszek, R.; Zuba, D. A comparison of developed and validated chromatographic methods (HPLC, GC-MS) for determination of delta-9-tetrahydrocannabinol and delta-9-tetrahydrocannabinolic acid in hemp. Probl. Forensic Sci. 2007, LXXI, 313–322. [Google Scholar]
- Valizadehderakhshan, M.; Shahbazi, A.; Kazem-Rostami, M.; Todd, M.S.; Bhowmik, A.; Wang, L. Extraction of Cannabinoids from Cannabis sativa L. (Hemp)—Review. Agriculture 2021, 11, 384. [Google Scholar] [CrossRef]
- Wang, M.; Wang, Y.H.; Avula, B.; Radwan, M.M.; Wanas, A.S.; van Antwerp, J.; Parcher, J.F.; ElSohly, M.A.; Khan, I.A. Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis Cannabinoid Res. 2016, 1, 262–271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Filer, C.N. Acidic Cannabinoid Decarboxylation. Cannabis Cannabinoid Res. 2022, 7, 262–273. [Google Scholar] [CrossRef]
- Department for Drug Policies (DPA). Parliament 2021 Report on Drug Addiction in Italy. Available online: https://www.politicheantidroga.gov.it/media/3076/rap2021pdf.pdf (accessed on 15 June 2023).
- National Centre for Addiction and Doping. SNAP—Sistema Nazionale di Allerta Precoce. 2019. Available online: https://www.iss.it/en/-/snap-sistema-nazionale-di-allerta-precoce-contro-la-droga (accessed on 22 May 2023).
- Department for Drug Policies (DPA). Parliament 2022 Report on Drug Addiction in Italy. 2022. Available online: https://www.iss.it/documents/20126/825192/relazione-al-parlamento-2022.pdf/1eab04ab-579c-9584-8dae-799ae419a929?t=1657173847902 (accessed on 15 June 2023).
- Zamengo, L.; Bettin, C.; Badocco, D.; Frison, G. Cannabis potency in North-East Italy: A ten-year study (2010–2019). Forensic Sci. Int. 2020, 317, 110556. [Google Scholar] [CrossRef]
- Chandra, S.; Radwan, M.M.; Majumdar, C.G.; Church, J.C.; Freeman, T.P.; ElSohly, M.A. New trends in cannabis potency in USA and Europe during the last decade (2008–2017). Eur. Arch. Psychiatry Clin. Neurosci. 2019, 269, 5–15. [Google Scholar] [CrossRef]
- Freeman, T.P.; Groshkova, T.; Cunningham, A.; Sedefov, R.; Griffiths, P.; Lynskey, M.T. Increasing potency and price of cannabis in Europe, 2006–2016. Addiction 2019, 114, 1015–1023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Petrilli, K.; Ofori, S.; Hines, L.; Taylor, G.; Adams, S.; Freeman, T.P. Association of cannabis potency with mental ill health and addiction: A systematic review. Lancet Psychiatry 2022, 9, 736–750. [Google Scholar] [CrossRef] [PubMed]
- van Laar, M.W.; Oomen, P.E.; van Miltenburg, C.J.A.; Vercoulen, E.; Freeman, T.P.; Hall, W.D. Cannabis and COVID-19: Reasons for Concern. Front. Psychiatry 2020, 11, 601653. [Google Scholar] [CrossRef] [PubMed]
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|---|---|
Sample size | 67 | 141 | 127 | 138 | 122 | 145 | 138 | 124 |
Minimum | 9.5 | 11.3 | 10.1 | 11.7 | 13.2 | 13.5 | 17.1 | 22.2 |
25% percentile | 10.8 | 12.4 | 12.5 | 13.4 | 16.5 | 14.7 | 20.6 | 25.2 |
Median | 14.5 | 14.2 | 14.3 | 14.8 | 17.8 | 17.6 | 21.4 | 27.6 |
75% percentile | 16.2 | 16.7 | 15.8 | 15.7 | 20.8 | 21.9 | 24.5 | 28.8 |
Maximum | 16.7 | 18.4 | 18.8 | 17.1 | 30.3 | 26.3 | 27.2 | 31.2 |
Range | 7.2 | 7.1 | 8.7 | 5.4 | 17.1 | 12.8 | 10.1 | 9.0 |
Mean | 13.7 | 14.6 | 14.2 | 14.5 | 19.2 | 18.3 | 22.0 | 27.1 |
SD | 2.7 | 2.5 | 2.2 | 1.7 | 4.9 | 4.0 | 2.9 | 2.5 |
Std. error of mean | 1.0 | 0.7 | 0.6 | 0.5 | 1.4 | 1.2 | 0.8 | 0.7 |
Males (%) | Females (%) | Sample Size (n) | ||
---|---|---|---|---|
2015 | Total | 82 (91.1%) | 8 (8.9%) | 90 |
Mean Age | 33 | 32 | ||
Minimum | 17 | 19 | ||
Maximum | 65 | 41 | ||
2016 | Total | 177 (92.2%) | 15 (7.8%) | 192 |
Mean Age | 32 | 38 | ||
Minimum | 17 | 19 | ||
Maximum | 67 | 72 | ||
2017 | Total | 143 (91.1%) | 14 (8.9%) | 157 |
Mean Age | 32 | 39 | ||
Minimum | 16 | 19 | ||
Maximum | 60 | 58 | ||
2018 | Total | 151 (89.3%) | 18 (10.7%) | 169 |
Mean Age | 32 | 40 | ||
Minimum | 18 | 20 | ||
Maximum | 79 | 59 | ||
2019 | Total | 137 (91.9%) | 12 (8.1%) | 149 |
Mean Age | 32 | 35 | ||
Minimum | 15 | 19 | ||
Maximum | 70 | 59 | ||
2020 | Total | 168 (91.8%) | 15 (8.2%) | 183 |
Mean Age | 33 | 35 | ||
Minimum | 18 | 21 | ||
Maximum | 72 | 66 | ||
2021 | Total | 146 (86.9%) | 22 (13.1%) | 168 |
Mean Age | 32 | 35 | ||
Minimum | 18 | 19 | ||
Maximum | 64 | 67 | ||
2022 | Total | 123 (94.6%) | 7 (5.4%) | 130 |
Mean Age | 32 | 25 | ||
Minimum | 19 | 25 | ||
Maximum | 57 | 27 |
No. of Samples | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
1030 | 1505 | 2128 | 2255 | 2534 | 2427 | 2830 | |
THC Content (%) | |||||||
Minimum | 1.0 | 0.3 | 0.8 | 0.7 | 0.5 | 0.6 | 0.6 |
Maximum | 35.0 | 39.0 | 55.0 | 67.0 | 62.0 | 78.0 | 74.0 |
Mean | 9.7 | 7.4 | 16.0 | 17.0 | 20.0 | 25.0 | 25.0 |
Median | 9.2 | 25.0 | 14.0 | 16.0 | 19.0 | 26.0 | 26.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vernich, F.; Stefani, L.; Fiorelli, D.; Mineo, F.; Pallocci, M.; Treglia, M.; Marsella, L.T.; Tittarelli, R. Trends in Illicit Cannabis Potency based on the Analysis of Law Enforcement Seizures in the Southern Area of Rome. Toxics 2023, 11, 648. https://doi.org/10.3390/toxics11080648
Vernich F, Stefani L, Fiorelli D, Mineo F, Pallocci M, Treglia M, Marsella LT, Tittarelli R. Trends in Illicit Cannabis Potency based on the Analysis of Law Enforcement Seizures in the Southern Area of Rome. Toxics. 2023; 11(8):648. https://doi.org/10.3390/toxics11080648
Chicago/Turabian StyleVernich, Francesca, Lucrezia Stefani, Denise Fiorelli, Federico Mineo, Margherita Pallocci, Michele Treglia, Luigi Tonino Marsella, and Roberta Tittarelli. 2023. "Trends in Illicit Cannabis Potency based on the Analysis of Law Enforcement Seizures in the Southern Area of Rome" Toxics 11, no. 8: 648. https://doi.org/10.3390/toxics11080648